Petrone Group is proud to announce the inception of its latest company – Euromed Pharma DACH GmbH. This venture is the last of a series of strategic steps undertaken to reinforce the position of our group in the global market, we strongly believe it will improve our direct access to one of the key European markets and will enable the growth of Group strategic services. Euromed Pharma DACH, through its Berlin office, will open its doors officially as of this week upon the completion of all relevant authorizations. It represents another step in offering a comprehensive and extensive portfolio of services to our clients.
Petrone Group strategic decision to set up a company in Germany is particularly driven by the need of consolidating two main drivers, i.e., Clinical Trial Supplies Services and Order to Cash Services for Orphan Drugs and Hospital Specialty Drug business lines.
The main focus of these divisions is:
With this initiative we hope to strengthen our relationships with our current German partners. and step after step. expand our reach under one unique big brand, i.e., Euromed Pharma. This German affiliate adds a big piece of the puzzle to our existing presence: almost 60 years in Italy, 23 years in Spain, 15 years in Ireland, 10 years in Singapore and the recent launch of our US office in 2019.
Euromed Pharma DACH GmbH
Willy-Brandt-Platz 2 12529 Schönefeld
WDA number: BB 01 WDA 2022/G3-6300
DE contact reference: phone +49 302 0849757 mobile +49 171 1611 762
fax: +49 302 0849758 e-mail firstname.lastname@example.org